Selpercatinib for RET-positive advanced pancreatic cancer detected by liquid biopsy: a case-based insight
{{output}}
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a poor prognosis and limited effective treatments. Standard chemotherapy offers modest survival benefits, and actionable genetic alterations are rare. RET gene fusions occur in less than ... ...
